Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
4.520
Zitationen
19
Autoren
2001
Jahr
Abstract
Treatment of postmenopausal osteoporosis with parathyroid hormone (1-34) decreases the risk of vertebral and nonvertebral fractures; increases vertebral, femoral, and total-body bone mineral density; and is well tolerated. The 40-microg dose increased bone mineral density more than the 20-microg dose but had similar effects on the risk of fracture and was more likely to have side effects.
Ähnliche Arbeiten
Vitamin D Deficiency
2007 · 13.430 Zit.
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 · 10.296 Zit.
How useful is SBF in predicting in vivo bone bioactivity?
2006 · 9.313 Zit.
Osteoporosis Prevention, Diagnosis, and Therapy
2001 · 5.453 Zit.
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
2006 · 4.603 Zit.